相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Risk for Immune-Mediated Graft Dysfunction in Liver Transplant Recipients With Recurrent HCV Infection Treated With Pegylated Interferon
Josh Levitsky et al.
GASTROENTEROLOGY (2012)
Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b-infected null responders
Kazuaki Chayama et al.
HEPATOLOGY (2012)
DUAL ORAL THERAPY WITH THE NS5A INHIBITOR DACLATASVIR (BMS-790052) AND NS3 PROTEASE INHIBITOR ASUNAPREVIR (BMS-650032) IN HCV GENOTYPE 1B-INFECTED NULL RESPONDERS OR INELIGIBLE/INTOLERANT TO PEGINTERFERON/RIBAVIRIN
F. Suzuki et al.
JOURNAL OF HEPATOLOGY (2012)
1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3
M. Sulkowski et al.
JOURNAL OF HEPATOLOGY (2012)
Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1
Anna S. Lok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Systematic review: anti-viral therapy of recurrent hepatitis C after liver transplantation
P. Guillouche et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Effect of the Hepatitis C Virus Protease Inhibitor Telaprevir on the Pharmacokinetics of Amlodipine and Atorvastatin
Jee Eun Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Hepatitis C Virus-Infected Women Have a Higher Risk of Advanced Fibrosis and Graft Loss After Liver Transplantation than Men
Jennifer C. Lai et al.
HEPATOLOGY (2011)
Effect of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus
Varun Garg et al.
HEPATOLOGY (2011)
Multiple Ascending Dose Study of BMS-790052, a Nonstructural Protein 5A Replication Complex Inhibitor, in Patients Infected with Hepatitis C Virus Genotype 1
Richard E. Nettles et al.
HEPATOLOGY (2011)
Genotypic and Phenotypic Analysis of Variants Resistant to Hepatitis C Virus Nonstructural Protein 5A Replication Complex Inhibitor BMS-790052 in Humans: In Vitro and In Vivo Correlations
Robert A. Fridell et al.
HEPATOLOGY (2011)
Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients
Nazia Selzner et al.
JOURNAL OF HEPATOLOGY (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
Bruce R. Bacon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Retreatment of HCV Infection
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Post-Liver Transplant Cholestatic Hepatitis C: A Systematic Review of Clinical and Pathological Findings and Application of Consensus Criteria
Torun K. Narang et al.
LIVER TRANSPLANTATION (2010)
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
B. J. Veldt et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Herpes zoster infection after liver transplantation in patients receiving induction therapy with alemtuzumab
Maria L. Alcaide et al.
CLINICAL TRANSPLANTATION (2008)
Recurrent hepatitis C after liver transplantation: On-treatment prediction of response to peginterferon/ribavirin therapy
Ibrahim A. Hanouneh et al.
LIVER TRANSPLANTATION (2008)
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence
Pratima Sharma et al.
LIVER TRANSPLANTATION (2007)
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation:: A randomized controlled study
Jose A. Carrion et al.
GASTROENTEROLOGY (2007)
Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation
Francesco Paolo Picciotto et al.
JOURNAL OF HEPATOLOGY (2007)
Hepatitis C is a risk factor for death after liver retransplantation
SJ Pelletier et al.
LIVER TRANSPLANTATION (2005)
Herpes zoster infection after liver transplantation: A case-control study
J Levitsky et al.
LIVER TRANSPLANTATION (2005)
Reconstitution of hepatitis C virus-specific T-cell-mediated immunity after liver transplantation
SJ Weston et al.
HEPATOLOGY (2005)
Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C
VI Machicao et al.
TRANSPLANTATION (2004)
Severe recurrent hepatitis C after liver retransplantation for hepatitis C virus-related graft cirrhosis
M Berenguer et al.
LIVER TRANSPLANTATION (2003)
Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection
M Kugelmas et al.
LIVER TRANSPLANTATION (2003)
The association between hepatitis C infection and survival after orthotopic liver transplantation
LM Forman et al.
GASTROENTEROLOGY (2002)
HCV-related fibrosis progression following liver transplantation:: increase in recent years
M Berenguer et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
